SLC10A2 and type 2 diabetes mellitus: Further studies are needed to define the global hormonal response including intestinal incretins, and the precise pathways affected in the liver under conditions of Slc10a2 functional abrogation in the diabetic state, and could lead to novel therapeutic interventions in hyperlipidemic states of disease, including type 2 diabetes.